Anti-PIK3CD monoclonal antibody

Pre-made anti-PIK3CD monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PIK3CD/PIK3CD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T67849-Ab-1/ GM-Tg-hg-T67849-Ab-2Anti-Human PIK3CD monoclonal antibodyHuman
GM-Tg-rg-T67849-Ab-1/ GM-Tg-rg-T67849-Ab-2Anti-Rat PIK3CD monoclonal antibodyRat
GM-Tg-mg-T67849-Ab-1/ GM-Tg-mg-T67849-Ab-2Anti-Mouse PIK3CD monoclonal antibodyMouse
GM-Tg-cynog-T67849-Ab-1/ GM-Tg-cynog-T67849-Ab-2Anti-Cynomolgus/ Rhesus macaque PIK3CD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T67849-Ab-1/ GM-Tg-felg-T67849-Ab-2Anti-Feline PIK3CD monoclonal antibodyFeline
GM-Tg-cang-T67849-Ab-1/ GM-Tg-cang-T67849-Ab-2Anti-Canine PIK3CD monoclonal antibodyCanine
GM-Tg-bovg-T67849-Ab-1/ GM-Tg-bovg-T67849-Ab-2Anti-Bovine PIK3CD monoclonal antibodyBovine
GM-Tg-equg-T67849-Ab-1/ GM-Tg-equg-T67849-Ab-2Anti-Equine PIK3CD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T67849-Ab-1/ GM-Tg-hg-T67849-Ab-2; GM-Tg-rg-T67849-Ab-1/ GM-Tg-rg-T67849-Ab-2;
GM-Tg-mg-T67849-Ab-1/ GM-Tg-mg-T67849-Ab-2; GM-Tg-cynog-T67849-Ab-1/ GM-Tg-cynog-T67849-Ab-2;
GM-Tg-felg-T67849-Ab-1/ GM-Tg-felg-T67849-Ab-2; GM-Tg-cang-T67849-Ab-1/ GM-Tg-cang-T67849-Ab-2;
GM-Tg-bovg-T67849-Ab-1/ GM-Tg-bovg-T67849-Ab-2; GM-Tg-equg-T67849-Ab-1/ GM-Tg-equg-T67849-Ab-2
Products NameAnti-PIK3CD monoclonal antibody
Formatmab
Target NamePIK3CD
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PIK3CD monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T67849-Ag-1Recombinant multi-species PK3CD/ PIK3CD/ APDS protein


    Target information

    Target IDGM-T67849
    Target NamePIK3CD
    Gene ID5293,18707,366508,710552,489644,101094274,504531,100051623
    Gene Symbol and Synonyms2410099E07Rik,2610208K16Rik,APDS,IMD14,IMD14A,IMD14B,p110D,P110DELTA,PI3K,PIK3CD,ROCHIS
    Uniprot AccessionO00329
    Uniprot Entry NamePK3CD_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000171608
    Target ClassificationKinase, Tumor-associated antigen (TAA)

    The target: PIK3CD, gene name: PIK3CD, also named as APDS, IMD14, P110DELTA, PI3K, p110D. Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.